Ipca Laboratories Ltd (IPCALAB) is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.
Ipca is a therapy leader in India for anti-malarials, DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for rheumatoid arthritis.
APIs - Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), FMetoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive), urosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), and Pyrantel Salts (anthelmintic).
Top 10 brands: Zerodol, Lariago (Chloroquine), HCQS (Hydroxychloroquine), Perinorm (Metoclopramide), Rapither (Artemotil), Tenoric, Lumerax (Artemether + Lumefantrine), Etova (Etodolac), Malirid (Primaquine) and Folitrax (Methotrexate).
Corporate Office
Ipca Laboratories Ltd.,
142 AB, Kandivli Industrial Estate, Kandivli (West)
Mumbai 400 067, Maharashtra
Phone: +91 (22) 6647 4747
Fax: +91 (22) 2868 6954 / 2875
Web : http://www.ipcalabs.com